Anesthesia Drugs Market By Type (General Anaesthetics [Propofol, Sevoflurane, Desflurane, Dexmedetomidine, Remifentanil, Midazolam], Local Anaesthetics [Bupivacaine, Ropivacaine, Lidocaine, Chloroprocaine, Articaine, Benzocaine]); By Application (General Surgeries, Plastic Surgery, Cosmetic Surgeries, Dental Surgeries); By Route Of Administration (Inhalation Anesthesia Drugs, Intravenous Anesthesia Drugs, Topical Anesthesia Drugs); By Geography, Segment Revenue Estimation, Forecast, 2024–2032.

Anesthesia Drugs Market Overview:

The Anesthesia Drugs Market was valued at USD 6.8 billion in 2020, is projected to reach approximately USD 7.81 billion by 2024, and is expected to grow further to around USD 9.60 billion by 2030, expanding at a CAGR of approximately 3.47%.           

 

Anesthesia can be described as a state of temporary unconsciousness, loss of pain perception, memory loss, and muscle relaxation. Most people associate the word Anesthesia as medically induced unconsciousness before surgery. Apart from the fact that Anesthesia may be a relief for those who want to avoid surgical pain, its risks can also be a concern for those who fear medically induced unconsciousness.

 

According to statistics from 2014, the death rate due to Anesthesia (although performed by Anaesthesiologists) during surgical procedures stayed steady at three per 10,000. Between the years 2010 and 2013, the rate of complications decreased to 4.65% from 11.84%. Nausea and vomiting were the most common minor side-effects of Anesthesia. In 3.2 million cases of Anesthesia administered during this period, this issue was reported in 36% of the cases.

 

Nearly 12% of cases reported medication errors (Anesthesia Overdose/Underdose) as the most common major complication. The following conditions increase the risk of Anesthesia complications: smoking, obstructive sleep apnoea, high blood pressure, obesity, diabetes, heart or lung ailments, alcoholism or Drugs allergies, or any history of Anesthesia complications. There will be a greater need for Anesthesia Drugs over the next decade as the elderly population is growing at a rapid pace hence more people will require medical care. Subsequently, it will give a boost to Anesthesia Drugs market share.

 

Significance of Anaesthetic Drugs in the Pharmaceutical Market: - Anesthesia is a medication that prevents you from feeling pain during surgical procedures. Anaesthetics are medications that vandalize pain and help patients to relax during surgical procedures. Anesthesia has various varieties and forms like General Anesthesia Drugs, regional Anesthesia, Epidural, Spinal Anesthesia and Nerve Block Anesthesia Drugs, Combined General and Epidural Anesthesia.  Each type of Anesthesia prevents different pain sensations. Some anaesthetics can numb certain parts of the body, while other medicines can numb the brain, thereby causing sleep during more invasive surgeries, such as those that take place in the abdomen, head, or chest.

 

Impact of Covid 19 on the Global Anesthesia Drugs Market: -

A slight decline in the demand for Anesthesia Drugs was observed in 2020 as a result of the pandemic, causing delays or cancellations of surgeries. According to a study published in the British Journal of Surgery, approximately 28.4 million elective surgeries were cancelled or postponed globally in May 2020 due to the disruption of hospital services caused by COVID-19. Nevertheless, as social activities are resuming, all elective surgeries that were delayed, are being performed now, which means that Anesthesia Drugs are being consumed in greater quantities resulting in the Anesthesia Drugs market gradually picking up market growth.

Market Dynamics: Driver, Restraints, Opportunity and Challenges

Market Drivers and Opportunities: Increasing number of surgeries, growing number of elderly population and advances in technology poised to boost the growth of the market

One of the major factors driving the anaesthetics market is the increase in the number of surgeries performed, which use anaesthetics during the surgical procedure. An increase in surgeries is primarily due to the increasing incidents of traumatic injuries and accidents requiring surgical procedures. World Health Organization's Global status report on road safety 2018 shows that there are 1.35 million road accidents every year, with 64 deaths per 100,000 vehicles.

 

Additionally, advances in technology in the delivery of Drugs, the development of specifically targeted medicines, the development of devices to monitor patient's physiological parameters during and after Anesthesia, and reduced side effects of anaesthetics are the driving factors that will boost the market growth. By 2050, one out of four people living in Europe and Northern America could be 65 years or older, according to the Department of Economic and Social Affairs of the United Nations. With an increase in the elderly population, chronic diseases such as cardiovascular and neurological are on the rise in older populations, further increasing the need for Anesthesia Drugs.

 

As of June 15, 2019, Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, which is used to sedate non-intubated patients before and/or during surgery, is available from Fresenius Kabi. Due to this, the market for Global Anesthesia Drugs is expected to grow.

 

Market Restraint: Lack of Infrastructure, Lack of Awareness and High cost of Drugs and procedures restraining the growth of the market

Anexpected restraint in the growth of the Anesthesia Drugs market is due to the lack of healthcare facilities in underdeveloped countries and remote areas, as well as the lack of Anesthesia doctors and certified Anesthesia nurses per capita. Additionally, during the forecast period, high prices of procedures and branded Drugs will hinder the growth of this market. Lack of Anesthesia awareness among the common masses is also a condition that negatively affects the Anesthesia Drugs market.

 

Market Challenges: Unintentional intraoperative awareness and is one of the major challenges to the Anesthesia market

Moreover, during the surgical process when general Anesthesia is given, approximately one or two people out of every 1000 may be unaware that they are partially awake. There is very little chance of experiencing pain, but this can also occur.  Since people are being given relaxation Drugs before surgeries, they cannot move or communicate their pain or awareness to the doctors. There is the possibility that this will cause patients long-term psychological problems, similar to post-traumatic stress disorder. This is called unintentional intraoperative awareness and it is one of the major challenges to the Anesthesia market.

 

Global Anesthesia Drugs Market is segmented into the following segments:

We have segmented the Global Anesthesia Drugs Market into:

• Type 

• Application 

• Route Of Administration 

• Regional

 

By Type, the Global Anesthesia Drugs Market has been classified into:

• General Anesthesia Drugs

• Local Anesthesia Drugs

General Anesthesia Drugs dominated the market owing to the increasing number of major surgeries around the world since it helped doctors to create individualized anaesthetic plans that balance the patient's history with the anticipated surgical plan that maximizes patient safety. 

Local Anesthesia Drugs, on the other hand, is growing at the fastest CAGR rate since it is considered safer than general Anesthesia due to the absence of systemic side effects.

 

By Application, the Global Anesthesia Drugs Market has been classified into:

• General Surgeries

• Plastic Surgery

• Cosmetic Surgeries

• Dental Surgeries

• Other Surgeries

General Surgery dominated the market as anaesthetics are widely used in these surgical procedures. The market is expected to grow significantly over the forecasted period. The market is being driven by the growing number of surgeries, ageing population with an increasing number of chronic diseases as well as technological advancements in Anesthesia. On the other hand, in 2019, nearly 1.8 million cosmetic surgical procedures were completed in the United States and 16.3 million cosmetic minimally-invasive procedures were performed, according to statistics from the American Society of Plastic Surgeons (ASPS).

 

By Route of Administration, the Global Anesthesia Drugs Market has been classified into:

• Inhalation

• Intravenous

• Others

The Intravenous Drugs dominated the Anesthesia Drugs market as it offers various advantages such as more accurate dose delivery, better patient safety, lower rates of (postoperative nausea, vomiting, urinary retention, and malignant hyperthermia (a rare but serious side effect of general Anesthesia)), reduced risk of blood clots and pulmonary emboli (blood clots that move to the lungs).

 

Regional Analysis: North America is witnessing a demand in Anesthesia Drugs due to increasing number of surgeries in the region.

The Anesthesia Drugs Market report includes Asia Pacific, North America, Europe and LAMEA.

North America is witnessing a huge surge in surgical procedures each year. In this region, ailments like cancer, heart disease, and cardiovascular disease are highly prevalent and increasing at a rapid pace. There is a plethora of growth opportunities in this market due to the prevalence of these surgeries. Forecasts for the US Anesthesia Drugs market indicates a robust upsurge which will attribute to the growth of the North America Anesthesia Drugs market. 

Moreover, the Asia Pacific region is projected to grow at the highest rate due to its rapidly expanding healthcare infrastructure and the presence of major players. The adoption of Anesthesia Drugs is increasing rapidly in this region which will drive high revenue growth among these regional players.

 

The report covers the following segments:

Global, regional, and country-wise revenue growth is forecasted in the report between 2021 to 2028. This report divides the Global Anesthesia Drugs market into:

By Type (Revenue, USD Billion, 2021 - 2028)

• General Anaesthetics

  • Propofol

  • Sevoflurane

  • Desflurane

  • Dexmedetomidine

  • Remifentanil

  • Midazolam

• Local Anaesthetics

  • Bupivacaine

  • Ropivacaine

  • Lidocaine

  • Chloroprocaine

  • Articaine

  • Benzocaine

 

By Application (Revenue, USD Billion, 2021 - 2028)

• General Surgeries

• Plastic Surgery

• Cosmetic Surgeries

• Dental Surgeries

 

By Route Of Administration (Revenue, USD Billion, 2021 - 2028)

• Inhalation Anesthesia Drugs

• Intravenous Anesthesia Drugs

• Topical Anesthesia Drugs

 

Company Usability Profiles:

Global Anesthesia Drugs Market report explores the recent significant developments by leading vendors, along with their in-depth company profiles, the key players included in the report are:

• Abbott Laboratories

• AbbVie Inc.

• Aspen Pharmacare Holdings Limited

• AstraZeneca PLC

• B. Braun Melsungen AG

• Baxter International Inc.

• Boehringer Ingelheim International GmbH

• Claris Lifesciences Limited

• Eisai Co. Ltd.

• F. Hoffmann-La Roche Ltd

• Fresenius SE & Co. KGaA

• Glenmark Pharmaceuticals Limited

• Hikma Pharmaceuticals PLC

• Hospira Inc

• Maruishi Pharmaceutical Co. Ltd. 

• Mylan NV

• Pacira Pharmaceuticals Inc. 

• Paion UK Ltd 

• Pfizer Inc. 

• Piramal Enterprises LTD 

• Septodont Healthcare India Pvt. Ltd. 

• Slayback Pharma LLC

• Teva Pharmaceutical Industries Limited

• Troikaa Pharmaceuticals Ltd.

 

Recent Development: -

• On 13th July 2021, Hikma Pharmaceuticals PLC (Hikma), an international pharma company, has launched Succiniylcholine Chloride Injection, USP 20mg/mL in the US, through its US affiliate, Hikma Pharmaceuticals USA Inc. In the treatment of COVID-19 patients Succinylcholine Chloride Injection, USP plays an important role. It is used to facilitate tracheal intubation as well as to relax skeletal muscles during a procedure or while on mechanical ventilation.

 

• On 10th October 2016, Agreement to acquire Janssen’s injectable Anesthesia and pain management products by Critical Care in the UK a wholly-owned subsidiary of Piramal Enterprises.